Skip to main content
. 2017 Mar 14;8(22):36339–36353. doi: 10.18632/oncotarget.16193

Table 3. Direct pairwise comparison results of esophageal cancer treatments.

Comparison 3-year OS 5-year OS DFS Recurrence Metastasis
CT+S vs S 0.88 (0.82, 0.93) 0.81 (0.76, 0.86) 0.76 (0.69,0.83) 0.85 (0.73, 1.00) 0.91 (0.72, 1.15)
CRT+S vs S 0.77 (0.69, 0.85) 0.70 (0.63, 0.78) 0.59 (0.53, 0.65) 0.70 (0.45, 1.08) 0.81 (0.58, 1.12)
RT+S vs S 1.05 (0.95, 1.15) 1.09 (0.99, 1.18) - - -
CRT+S vs CT+S 0.60 (0.44, 0.75) 0.64 (0.49, 0.78) 0.74 (0.50, 0.99) 0.73 (0.44, 1.23) -

Abbreviation: OS-Overall survival, DFS-Disease-free survival.

Note: The data of 3-year OS, 5-year OS and DFS is HR (hazard ratio) and 95% confidence interval. The results of reccurence and matastasis are OR (odds ratio) and 95% confidence interval.